BRIEF — Nyrada Receives Written FDA Feedback For Xolatryp Cardioprotection Program
Oct 13 (Reuters) — Nyrada Inc: Receives Written Fda Feedback On Pre-ind For Xolatryp Cardioprotection Program Further company coverage: NYR.AX (Reuters.Briefs@thomsonreuters.com)